Engflag

Addyzoa

Quick links to important sections

Addyzoa

Addyzoa_RO

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Addyzoa

Property Description
Active Ingredient Polyherbal and Herbo-mineral Blend
Form Oral Capsule
Pharmacological Class Spermatogenic Antioxidant / Reproductive Tonic
General Purpose Support for Male Reproductive Health
Origin Ayurvedic Medicine (Natural/Traditional)

Addyzoa: Definition and Classification as a Herbomineral Tonic

Addyzoa is a proprietary, multi-component herbomineral formulation originating from the traditional system of Ayurvedic medicine, primarily classified as a Spermatogenic Antioxidant. Developed by Charak Pharma Pvt Ltd (India), this product is positioned as a natural-source alternative intended to support male reproductive health. The formulation utilizes the traditional Ayurvedic principle of combining multiple natural ingredients to achieve a broad, systemic effect.

The classification as a Spermatogenic Antioxidant is supported by pharmacological studies that confirm the capacity of its key components to manage oxidative stress, a factor widely recognized in scientific literature to negatively influence male reproductive cell health. The use of traditional systems of medicine like Ayurveda, which combines ingredients from plants, minerals, and metals, is a centuries-old practice in India.

What is Addyzoa Made Of? Composition and Dosage Form

Addyzoa is a combination product of natural origin, delivered in a solid Oral Capsule form for controlled consumption. Its composition is distinctive, comprising a synergistic blend of over fifteen distinct traditional constituents. The formulation incorporates highly-regarded botanical extracts such as Withania Somnifera (Ashwagandha) and Purified Mucuna Pruriens, which are renowned for their adaptogenic and reproductive tonic properties in traditional texts. These are expertly integrated with purified herbo-mineral entities, like Asphaltum (Shilajit Shuddha), providing a comprehensive, polyherbal matrix designed to offer broad-spectrum support.

What is the General Purpose of Addyzoa?

The general purpose of Addyzoa is to offer support to men by helping maintain the overall health and function of the male reproductive system. This is achieved by targeting excessive oxidative stress—a key factor in the impairment of reproductive cells—through its primary action as a targeted antioxidant. Research highlighting the traditional use of its ingredients indicates that the product is intended to assist the natural maturation process known as spermatogenesis. This supports the product's role in helping to maintain the key indicators of reproductive potential, specifically the quality and motility of the reproductive cells.

Regulatory References

  1. Ministry of AYUSH Regulatory Framework

What side effects are possible with Addyzoa?

Possible Side Effects and Safety Information

The safety profile for Addyzoa is established based on its classification as a proprietary Ayurvedic herbomineral formulation. The available official safety documentation, including clinical assessments, has reported an absence of specific adverse effects during the study periods for this product in male patients. This means that standard pharmaceutical classifications for adverse reaction frequency (e.g., common, rare) and specific effects on organ systems (e.g., gastrointestinal, neurological) are not applicable as no such events were listed.

Safety Constraints and Considerations

Due to its composition as a herbo-mineral product (Ras aushadhi), which includes purified mineral components, the formulation's use is subject to specific regulatory constraints:

  • Mandatory Supervision: The product is required to be used under strict medical supervision. This is a high-level safety requirement consistent with the regulatory principles for complex traditional medicines containing minerals.
  • Population-Specific Exclusion: The safety information advises that the formulation is best avoided during pregnancy and lactation.
  • Pre-existing Conditions: Caution and medical oversight are prudent for individuals with severe hepatic or renal impairment, consistent with the general safety guidelines for this class of medicine.
  • Duration of Use: Safety documentation for this formulation supports its suitability for long-term use.

In summary, the official safety framework is characterized by the documented absence of adverse reactions, coupled with procedural safety constraints requiring professional oversight due to the nature of the herbo-mineral ingredients.

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

The information below summarizes official regulatory guidance concerning over-exposure to Addyzoa, a multi-component herbomineral formulation. Specific clinical manifestations for acute overdose of the proprietary blend are not formally documented in standard regulatory prescribing information.

Overdose Scope

Category Official Regulatory Statement
Documented Overdose Presentations No specific clinical signs are formally documented for the proprietary blend. The primary documented toxicological concern for this product class is heavy metal toxicity, which may present with:
• Gastrointestinal distress (abdominal pain, vomiting).
• Nervous system symptoms (confusion, dizziness, tingling/burning sensations).
Physiological Systems Affected Potential for injury to the renal system (kidney injury) and effects on the cardiovascular system (high blood pressure) are known risks associated with the herbo-mineral product class, based on official warnings.
Emergency-Response Statements Management relies on symptomatic and supportive treatment. Attention to vital functions and close monitoring of blood pressure and cardiac rhythm are required steps.
When Immediate Medical Help is Required Seek immediate medical attention for any suspected overdose. Consult a poison control center (1-800-222-1222) or a healthcare provider if symptoms of possible heavy metal poisoning are suspected, as advised by regulatory authorities.

Official Overdose Statements

The regulatory profile mandates that all suspected over-exposure cases must be managed through symptomatic and supportive treatment, as no specific antidote is known for the complex formulation. The potential for severe outcomes, particularly kidney injury, associated with the herbo-mineral class requires that patients seek immediate medical attention to allow for monitoring and intervention.

Therapeutic Uses of Addyzoa

The primary therapeutic domain of Addyzoa is applied across domains where additional symptomatic support may be appropriate in contexts involving heightened systemic burden related to male reproductive health. It is commonly used to help with symptoms related to inflammatory or irritative states, such as those associated with functional stability becoming affected. The formulation includes traditional ingredients like Withania somnifera (Ashwagandha) and Mucuna pruriens (Kapikachchhu).

The herbomineral supplement, Addyzoa®, is recognized for its use in situations where individuals experience symptomatic burden related to male reproductive health. In this context, it is considered relevant for easing symptoms linked to organ-specific functional stress, specifically in conditions presenting with systemic or localized discomfort and symptoms linked to organ-specific functional stress.

In clinical settings that involve acute or unstable symptom patterns, the herbomineral components may assist with maintaining functional stability when symptoms are more noticeable. This supportive relief contributes to easing the overall symptom load and is relevant when supportive symptom management is appropriate. This product provides support that helps ease the overall symptom burden.

“This process supports general well-being during symptomatic phases.”

Quick Fact: Relevant for Easing symptoms that interfere with daily functioning

Eligibility and Restrictions for Use

Who Can and Cannot Use Addyzoa? - Official Eligibility Information

Eligibility for Addyzoa is determined by official regulatory labeling, which focuses on specific age groups and physiological states. This information reflects restrictions and requirements for use as documented in regulatory sources for traditional medicine.

Eligibility Status Summary

Population Group Official Regulatory Status
Children Not Recommended. Safety and efficacy are not established for pediatric use.
Pregnant Women Not Recommended. Use during pregnancy should be avoided.
Lactating Women Restricted Use. Consultation with a doctor is necessary before use during breastfeeding.
Adult Men Eligible. Intended for use in this population.

Mandatory Restrictions

All use of Addyzoa must be undertaken under medical supervision only, as specified in the product's official labeling. No absolute non-allergic contraindications are explicitly listed; however, its use is strongly restricted in the special populations noted above. The product is primarily intended for use in adult men.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official documentation regarding interaction patterns for the proprietary Addyzoa product is based on the interaction potential of its key components: Withania Somnifera and Purified Mucuna Pruriens (L-DOPA content). These interactions are classified as either pharmacokinetic or pharmacodynamic.

Pharmacodynamic Interaction Patterns

Co-administration with certain substance categories may result in additive effects, as defined in regulatory-aligned resources:

Interacting Agents Documented Outcome Basis of Interaction
Sedatives and Hypnotics Risk of increased Central Nervous System (CNS) depression. Pharmacodynamic
Dopaminergic Agents Risk of additive dopaminergic effects. Pharmacodynamic
Monoamine Oxidase Inhibitors (MAOIs) Documented risk of an adverse hypertensive event. Pharmacodynamic
Alcohol May result in synergistic CNS depression. Pharmacodynamic

Pharmacokinetic Interaction Patterns

There is a documented potential for the component Withania Somnifera to modulate drug clearance via enzyme pathways, which may alter the systemic exposure of co-administered medicines:

Interacting Agents Documented Outcome Basis of Interaction
CYP2D6 Substrates Potential for increased plasma concentration. Pharmacokinetic (Enzyme Modulation)
CYP3A4 Substrates Potential for increased systemic exposure. Pharmacokinetic (Enzyme Modulation)

These patterns structure the official interaction profile, which focuses on additive effects within the CNS and dopaminergic systems, and the alteration of clearance for medicines metabolized by CYP2D6 and CYP3A4. No mandatory timing separation rules are formally documented.

Mechanism of Action

Modulating Cellular Processes and Regulation

Addyzoa's mechanism of action involves influencing multiple biochemical pathways critical to male reproductive function. The compound initiates a free radical scavenging action by modulating reactive oxygen species (ROS) levels within the testicular environment. This action directly affects membrane lipid peroxidation processes in germ cells, resulting in a modification of the oxidative microenvironment within the seminiferous tubules.

Simultaneously, the components influence early molecular steps by supplying key metabolic elements for cellular signaling. This engages metabolic pathways that influence the rate of cellular proliferation and differentiation during spermatogenesis, thereby impacting the biophysical characteristics of developing sperm. Furthermore, it contributes to pathways involving enzyme-mediated signaling in the sperm's midpiece, influencing the efficiency of mitochondrial respiration and ATP generation. This affects the availability of energy reserves for flagellar movement, modulating the spermatozoa's kinetic profile. The mechanism also influences hypothalamic-pituitary-gonadal (HPG) axis feedback regulation, thereby modulating the local concentration of steroid hormones and growth factors within the seminiferous tubules.

Dosage and Administration Information

Addyzoa is a proprietary herbo-mineral supplement formulated to support male reproductive health, primarily by addressing conditions such as oligoasthenoteratospermia (iOATs) which involves low sperm count and motility. The product is intended to be used under medical supervision as part of a therapeutic regimen.

General Administration

The dosage and duration of Addyzoa therapy should be determined by a healthcare provider based on the individual's specific diagnosis, semen parameters, and overall health status. This is important as the application of such supplements is typically managed within the context of clinical observation and specific therapeutic goals.

Condition Based on Sperm Count Recommended Adult Dosage (General Guidance) Duration of Use
Sperm Count <10 million/mL 2 capsules, three times daily Typically 3 months
Sperm Count >10 million/mL 1 capsule, three times daily Typically 3 months

Important Considerations

  • Consistency: The duration of treatment, often around three months, is based on the time required for the full cycle of spermatogenesis (sperm development and maturation).
  • Intake: While some traditional instructions suggest taking the capsule on an empty stomach, it is a common practice to take the capsule with water after meals to support optimal absorption and tolerability. Always follow the precise instructions given by your prescribing physician.
  • Monitoring: Regular follow-up and semen analysis are essential during and after the course of therapy to monitor the supplement's effects on sperm quality and count.
  • Adverse Reactions: Discontinue use and consult a physician immediately if any adverse effects or allergic reactions occur.

Recent Clinical Evidence

Addyzoa: Recent Clinical Evidence

Addyzoa is a proprietary herbomineral formulation, and research concerning its use generally focuses on its influence on male semen parameters, particularly in cases of low sperm count (oligospermia) and reduced sperm motility (asthenospermia). The ingredients are often studied for their established antioxidant and adaptogenic properties.

Studies have been conducted to evaluate the effects of Addyzoa on key indicators of sperm health. Findings from different trials explore changes in count, motility, and morphology in men with idiopathic infertility (infertility with no known cause).

Clinical Findings Summary

Parameter Investigated Key Findings Reported in Studies
Sperm Motility Randomized, controlled trials reported a significant improvement in mean total motility and progressive motility after approximately three months of use in men with oligoasthenoteratospermia.
Sperm Concentration/Count Some studies suggested an increase in sperm concentration, particularly in mild to moderate oligospermia, compared to baseline values. Other randomized trials did not report a significant change in sperm concentration compared to a placebo group.
Sperm Morphology Limited data has examined the effect on the percentage of normal sperm forms. Comparative studies have investigated its effect against other pharmacological agents.
Safety and Side Effects Clinical assessments have reported that the formulation was generally well-tolerated across the duration of the studies, with no major adverse events recorded in the reviewed populations.

Overall, the current body of evidence primarily points to an association with improvements in sperm motility. Research continues to investigate the specific components—such as Withania somnifera (Ashwagandha) and Mucuna pruriens—for their roles in managing oxidative stress and supporting reproductive health, which is the proposed mechanism of action for this type of supplement.

Key Studies & References

  1. Herbo-mineral supplementation in men with idiopathic oligoasthenoteratospermia: A double blind randomized placebo-controlled trial
  2. Guidelines on Approval of Clinical Trial & New Drugs (CDSCO Regulatory Context)

Frequently Asked Questions (FAQ)

Common questions about Addyzoa (FAQ)

Q: What is the intended use of Addyzoa?

A: Addyzoa is indicated for managing conditions such as oligospermia (low sperm count) and teratozoospermia (abnormal sperm forms). The official product information cites its use in supporting the overall quality of semen parameters. This product is generally intended for men facing infertility related to these specific semen deficiencies.

Q: How does Addyzoa work?

A: Official information suggests Addyzoa is formulated to aid in supporting sperm health and function. It is reported to help increase sperm count and enhance motility (the sperm's ability to move effectively). The formulation is reported in regulatory documents to help improve overall semen quality parameters.

Q: What are the common ingredients in Addyzoa?

A: Addyzoa contains a combination of herbs and minerals, based on the formulation listed in the official product information. Key ingredients include Kapikachchhu (Mucuna pruriens), Ashwagandha (Withania somnifera), and Gokshura (Tribulus terrestris). Other components, such as Jatiphala (Myristica fragrans) and Shilajit, are also present.

Q: How long does it take to see effects from Addyzoa?

A: Regulatory documents state that achieving maximum benefits from Addyzoa may take time due to the natural cycle of sperm production. Official product information indicates that the desired effects may typically be observed after a continuous period of several months. The product label often suggests that treatment may be required for 3 to 6 months for best results.

Q: Can Addyzoa be used for conditions other than low sperm count?

A: According to the official product information, Addyzoa is specifically indicated for improving semen quality in men with conditions like oligospermia (low sperm count) and teratozoospermia (abnormal sperm shape). Its use is focused solely on male infertility related to these specific semen parameters. The regulatory documents do not describe or support its use for other conditions.

How should Addyzoa be stored and disposed of?

Official Storage and Disposal Instructions

The required storage and handling conditions for Addyzoa capsules are defined by the product's official labeling to maintain the stability of its herbomineral composition. The product must be stored in a cool and dry place, requiring protection from light and humidity, with explicit warnings against exposure to high temperatures or freezing.

Regulatory documents mandate that the product be kept in its original container and that it remains out of the reach of children. When the product is no longer needed or has expired, the official instruction is to dispose off the unused medicine according to local guidelines for non-hazardous drug waste, ensuring proper environmental and public health mitigation.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Addyzoa found in:

A-Z Index: